Current Insights into Diagnosis, Prevention Strategies, Treatment, Therapeutic Targets, and Challenges of Monkeypox (Mpox) Infections in Human Populations
Author:
Patel Mitesh1ORCID, Adnan Mohd2ORCID, Aldarhami Abdu3ORCID, Bazaid Abdulrahman4ORCID, Saeedi Nizar5ORCID, Alkayyal Almohanad5ORCID, Saleh Fayez6ORCID, Awadh Ibrahim7, Saeed Amir4, Alshaghdali Khalid4
Affiliation:
1. Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India 2. Department of Biology, College of Science, University of Ha’il, Hail P.O. Box 2440, Saudi Arabia 3. Department of Medical Microbiology, Qunfudah Faculty of Medicine, Umm Al-Qura University, Al-Qunfudah 21961, Saudi Arabia 4. Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Hail, Hail 55476, Saudi Arabia 5. Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk 71491, Saudi Arabia 6. Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia 7. Laboratory and Blood Bank Department, Qunfudah General Hospital, Al-Qunfudah 28821, Saudi Arabia
Abstract
In the wake of the emergence and worldwide respread of a viral infection called Monkeypox (Mpox), there is a serious threat to the health and safety of the global population. This viral infection was endemic to the western and central parts of Africa, but has recently spread out of this endemic area to various countries, including the United Kingdom (UK), Portugal, Spain, the United States of America (USA), Canada, Sweden, Belgium, Italy, Australia, Germany, France, the Netherlands, Israel, and Mexico. This is a timely review focusing on recent findings and developments in the epidemiology, clinical features, therapeutic targets, diagnosis, prevention mechanisms, research challenges and possible treatment for Mpox. To date (29 November 2022), there have been around 81,225 reported cases of Mpox. In most cases, this illness is mild; however, there is a fatality rate ranging from 1 to 10%, which might be increased due to associated complications and/or secondary infections. There is a real challenge in the diagnosis of Mpox, since its symptoms are very similar to those of other infections, including smallpox and chickenpox. Generally, to prevent/limit the risk and transmission of Mpox, the detection and isolation of infected individuals, as well as hand hygiene and cleanliness, are essential and effective approaches to control/combat this viral infection. Nevertheless, updated information about Mpox from different angles is lacking. Thus, this review provides updated and comprehensive information about the Mpox illness, which should highlight the global burden, pathogenicity, symptoms, diagnosis, prevention measures and possible treatment of this emerging disease.
Funder
Deanship of Scientific Research
Subject
Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics
Reference102 articles.
1. Clinical Features and Management of Human Monkeypox: A Retrospective Observational Study in the UK;Adler;Lancet Infect. Dis.,2022 2. A Human Infection Caused by Monkeypox Virus in Basankusu Territory, Democratic Republic of the Congo;Ladnyj;Bull. World Health Organ.,1972 3. Diagnosis and Management of Smallpox;Breman;N. Engl. J. Med.,2002 4. Human Monkeypox, 1970–1979;Breman;Bull. World Health Organ.,1980 5. Status of Human Monkeypox: Clinical Disease, Epidemiology and Research;Damon;Vaccine,2011
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|